Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2017; 42(3): 316-319


in vitro susceptibility pattern of methicillin resistant staphylococcus aureus isolates to animicrobials quinupristin-dalfopristin and linezolid

Ali Faraz, Muhammad Asad Farhan, Kashif Shaikh, Tahir Ansari, Shafqat Ali, Usama Bin Ghaffar.




Abstract

Objective: To detect in vitro efficacy of antimicrobials Quinupristin-dalfopristin and linezolid against methicillin-resistant Staphylococcus aureus (MRSA) isolates .
Methodology: One hundred MRSA isolates at the department of Microbiology, Armed Forces Institute of Pathology (AFIP), Rawalpindi and department of Microbiology, Army Medical College (AMC), Rawalpindi, were studied. MRSA were identified by using 1µg oxacillin disk and confirmed by Polymerase chain reaction (PCR) for mecA gene. MRSA isolates were then tested against Linezolid & Quinupristin-dalfopristin disc using disk diffusion method, as per CLSI guidelines. After over night incubation at 35+oC zone of inhibition around the disc was read and interpreted.
Results: Out of 100 isolates, none were found resistant to either Linezolid or Quinupristin-dalfopristin .
Conclusions: These two antimicrobials streptogramin quinupristin-dalfopristin, and the oxazolidinone linezolid, have good in vitro activity against MRSA. These drugs are promising therapeutic options in an era of rapidly growing antibiotic resistance.

Key words: MRSA, Antibiotic susceptibility, Qunupistin-dalfopristin, Linezolid.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.